nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0473	0.0738	CbGpPWpGaD
Pasireotide—SSTR3—nervous system—Gilles de la Tourette syndrome	0.0468	0.13	CbGeAlD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0454	0.0708	CbGpPWpGaD
Pasireotide—SSTR3—central nervous system—Gilles de la Tourette syndrome	0.045	0.125	CbGeAlD
Pasireotide—SSTR1—midbrain—Gilles de la Tourette syndrome	0.045	0.125	CbGeAlD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0402	0.0628	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0371	0.0579	CbGpPWpGaD
Pasireotide—SSTR1—nervous system—Gilles de la Tourette syndrome	0.037	0.103	CbGeAlD
Pasireotide—SSTR3—brain—Gilles de la Tourette syndrome	0.0357	0.0996	CbGeAlD
Pasireotide—SSTR1—central nervous system—Gilles de la Tourette syndrome	0.0356	0.0991	CbGeAlD
Pasireotide—SSTR2—nervous system—Gilles de la Tourette syndrome	0.0314	0.0876	CbGeAlD
Pasireotide—SSTR2—central nervous system—Gilles de la Tourette syndrome	0.0303	0.0843	CbGeAlD
Pasireotide—SSTR1—brain—Gilles de la Tourette syndrome	0.0283	0.0787	CbGeAlD
Pasireotide—SSTR2—brain—Gilles de la Tourette syndrome	0.024	0.0669	CbGeAlD
Pasireotide—SSTR2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0141	0.0219	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0137	0.0213	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00891	0.0139	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00839	0.0131	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00815	0.0127	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00804	0.0125	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00781	0.0122	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00779	0.0121	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00759	0.0118	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00756	0.0118	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00747	0.0116	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00727	0.0113	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00725	0.0113	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00713	0.0111	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00707	0.011	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00704	0.011	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00693	0.0108	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00675	0.0105	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00667	0.0104	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00662	0.0103	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00658	0.0103	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00648	0.0101	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00645	0.0101	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00643	0.01	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0064	0.00998	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00639	0.00997	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00621	0.00969	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00611	0.00953	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00603	0.00941	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00599	0.00934	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00595	0.00929	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00593	0.00925	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00579	0.00903	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00578	0.00902	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00567	0.00885	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00553	0.00862	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00551	0.00859	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00523	0.00817	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00513	0.008	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00508	0.00793	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00508	0.00792	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00493	0.00769	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00493	0.00769	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00487	0.0076	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00473	0.00739	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00473	0.00738	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00473	0.00738	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00459	0.00717	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0044	0.00687	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00432	0.00674	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00423	0.00659	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00419	0.00654	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00419	0.00654	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00405	0.00632	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00399	0.00622	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00391	0.00609	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00387	0.00604	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00387	0.00604	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00361	0.00562	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00359	0.0056	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00332	0.00517	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00322	0.00502	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00308	0.00481	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00287	0.00448	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00279	0.00435	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00275	0.00429	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00274	0.00427	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00267	0.00417	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00261	0.00407	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0026	0.00405	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00253	0.00395	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00252	0.00394	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0025	0.0039	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00249	0.00388	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00244	0.00381	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00243	0.00379	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00237	0.0037	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00236	0.00368	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00226	0.00353	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00225	0.00351	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00222	0.00346	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00221	0.00344	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00219	0.00341	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00215	0.00336	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00205	0.00319	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00204	0.00318	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.002	0.00313	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00199	0.0031	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00185	0.00289	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00182	0.00284	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00174	0.00272	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00165	0.00258	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00158	0.00247	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00155	0.00241	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00154	0.0024	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0015	0.00233	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00148	0.0023	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00143	0.00224	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00223	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0014	0.00219	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00139	0.00217	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00134	0.00208	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00131	0.00204	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0013	0.00202	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00127	0.00198	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00121	0.00189	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00118	0.00185	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00117	0.00183	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00109	0.0017	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000975	0.00152	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000935	0.00146	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000829	0.00129	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000765	0.00119	CbGpPWpGaD
